S&P 500 Gains and Losses Today: Johnson & Johnson Stock Jumps; Universal Health Services Shares Slide

U.S. equities, including the S&P 500, rose on Wednesday with gains across major indexes, as President Trump refuted reports of an imminent dismissal of Fed Chair Jerome Powell. Johnson & Johnson shares jumped 6.2% after exceeding Q2 sales and profit forecasts and boosting full-year guidance, while Global Payments surged 6.5% following reports of activist investor Elliott Management accumulating a significant stake. Conversely, Universal Health Services fell 3.8% after a BofA downgrade citing healthcare legislation headwinds, and Ansys dropped 4.7% post-conditional approval of its Synopsys buyout, giving back earlier gains. Micron Technology also declined 3.1% after Goldman Sachs initiated coverage with a neutral rating, reflecting caution in the semiconductor space.

Analysis

U.S. equity markets posted modest gains, with the S&P 500 rising 0.3%, as political uncertainty eased following President Trump's refutation of reports about the imminent dismissal of the Federal Reserve Chair. The market's advance was supported by significant single-stock movements driven by fundamental news and investor actions. Johnson & Johnson (JNJ) provided a strong positive catalyst, surging 6.2% after exceeding second-quarter sales and profit forecasts and raising its full-year guidance. Simultaneously, Global Payments (GPN) became the S&P 500's top performer, jumping 6.5% on news that activist investor Elliott Management has acquired a significant stake, signaling potential strategic shifts to unlock value after its stock declined following the Worldpay acquisition announcement. Conversely, specific sectors faced headwinds. Universal Health Services (UHS) dropped 3.8% after a Bank of America downgrade to "underperform," citing material risks from potential healthcare legislation that could compress patient volumes and increase bad debt. In the technology sector, Ansys (ANSS) fell 4.7% as it is set to be acquired by Synopsys and removed from the S&P 500, while Micron Technology (MU) declined 3.1% after Goldman Sachs initiated coverage with a cautious "neutral" rating, anticipating stable semiconductor revenues through next year despite a potential NAND market rebound in 2026.

Key Decisions for Investors

• Given Johnson & Johnson's strong Q2 results and upwardly revised full-year guidance, investors could interpret its 6.2% stock surge as fundamentally justified, supporting a continued positive outlook.
• The 6.5% jump in Global Payments on news of an Elliott Management stake suggests investors should monitor for activist-driven catalysts, such as strategic reviews or operational changes, aimed at unlocking shareholder value.
• Investors in Universal Health Services should exercise caution, as the BofA downgrade highlights significant downside risk tied to potential legislative changes to Medicaid and the ACA, which could directly impact the company's profitability.
• The neutral initiation on Micron Technology suggests a balanced risk-reward profile; while a 2026 NAND market recovery presents long-term potential, Goldman Sachs' cautious sector-wide view implies limited near-term upside.
• Ansys shareholders should anticipate further volatility from merger-arbitrage trading and technical selling pressure from index funds as its acquisition by Synopsys and subsequent removal from the S&P 500 approach.